- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Auna S.A.(AUNA)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for AUNA
11/13/2026: AUNA (1-star) is currently NOT-A-BUY. Pass it for now.
Auna S.A. is a Latin American healthcare operator running hospital networks and prepaid medical plans across Peru, Colombia, and Mexico. The company's primary strength lies in its vertically integrated Oncosalud oncology business in Peru, which generates stable cash flows. Its main growth opportunity stems from expanding ambulatory networks and capturing rising demand for private healthcare. However, heavy balance sheet debt and operational underperformance in Mexico present notable risks. The stock suits risk-tolerant growth investors willing to monitor debt reduction and operational turnarounds across emerging markets.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While Peru operations exhibit steady growth, contraction in Mexico weighs on consolidated expansion. |
| Momentum investor | Weak fit | The stock lacks sustained upward price momentum, making it conditional on a positive technical upturn signal. |
| Value investor | Mixed fit | Low forward earnings multiples are counterbalanced by heavy balance sheet leverage and debt risks. |
| Dividend investor | Weak fit | The company does not pay dividends, focusing instead on capital deployment and debt service. |
| Low-risk investor | Weak fit | High financial leverage, currency exposure, and regional volatility create substantial risk. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock experiences notable price swings characteristic of small-cap emerging market listings. |
| Valuation risk | Medium | Low earnings multiples reflect discounted pricing due to underlying structural concerns. |
| Competition risk (regional hospital and managed-care competition) | High | Auna competes against deeply entrenched local hospital networks in fragmented markets like Mexico. |
| Business quality | Medium | The Oncosalud franchise is high quality, but dragged down by weaker performance in international subsidiaries. |
| Dividend income | Low / none | No dividend distributions are currently offered to shareholders. |
| Execution risk | High | Successfully turning around operations in Mexico and managing heavy debt obligations requires flawless execution. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 339.92M USD | Price to earnings Ratio 76.5 | 1Y Target Price 6.99 |
Price to earnings Ratio 76.5 | 1Y Target Price 6.99 | ||
Volume (30-day avg) 180.1K shares | Beta 0.66 | 52 Weeks Range 4.09 - 6.29 | Updated Date 11/15/2026 |
52 Weeks Range 4.09 - 6.29 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.06 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Care Facilities
- BUY participation
- 88.9%
- Active BUY / eligible
- 8 / 9
- 30-Day BUY Count Change
- +6
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Downtrend
The stock has experienced a sustained decline in price over recent periods.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -48.41% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Oncosalud Peru (Managed Care) | Recurring membership premiums collected for prepaid oncology plans and specialized cancer care. | Provides stable, predictable subscription-like cash flows from health plan members. |
| Healthcare Services (Peru, Colombia, Mexico) | Revenues from inpatient hospital stays, surgeries, emergency room visits, and outpatient clinics. | Generates revenue fee-for-service through physical medical infrastructure and patient care. |
| Ancillary Services & Insurance | Sales of dental and vision insurance plans alongside pharmaceutical dispensing. | Offers diversified supplementary revenue streams outside core hospital operations. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-17 | When After Market | Estimate 0.27 | Actual - |
Profitability
Profit Margin 0.35% | Operating Margin (TTM) 13.39% |
Management Effectiveness
Return on Assets (TTM) 5.22% | Return on Equity (TTM) 1.62% |
Valuation
Trailing PE 76.5 | Forward PE - | Enterprise Value 1.26B | Price to Sales(TTM) 0.07 |
Enterprise Value 1.26B | Price to Sales(TTM) 0.07 | ||
Enterprise Value to Revenue 0.95 | Enterprise Value to EBITDA 6.02 | Shares Outstanding 30.14M | Shares Floating 27.44M |
Shares Outstanding 30.14M | Shares Floating 27.44M | ||
Percent Insiders 3.97 | Percent Institutions 78.57 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

